arginyl-glycyl-aspartic acid has been researched along with Marfan Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthel, F; Booms, P; Mundlos, S; Ney, A; Pletschacher, A; Pregla, R; Reinhardt, DP; Robinson, PN | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Marfan Syndrome
| Article | Year |
|---|---|
RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome.
Topics: Enzyme Induction; Fibrillin-1; Fibrillins; Humans; Marfan Syndrome; Matrix Metalloproteinases; Microfilament Proteins; Oligopeptides; Peptide Fragments; Sequence Analysis, Protein | 2005 |